Of note, although AFP was the most widely used serum biomarker for HCC diagnosis [39], its serum level as a continuous variable could not accurately predict post-surgical prognosis of HBV-related HCC patients, with AUCs of 0.550 and 0.565 for 5-year OS in the training and validation sets. The gene discussed is AFP; the disease is hepatocellular carcinoma.